Syncom Formulations Faces Significant Volatility Amid Bearish Market Indicators

Syncom Formulations (India) Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant volatility today, opening with a loss of 7.82%. The stock has underperformed compared to its sector, trailing by 1.83%. Over the past two days, Syncom has seen a consecutive decline, accumulating a total drop of 5.66%.
In terms of technical indicators, Syncom is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, reflecting a bearish trend. The stock's performance over the last month shows a decline of 8.94%, contrasting sharply with the Sensex, which has gained 7.86% during the same period.

The MACD indicates a bearish outlook on a weekly basis, while the monthly perspective is mildly bearish. The Bollinger Bands also suggest a bearish trend, and the KST shows mixed signals with a mildly bullish weekly reading but a mildly bearish monthly outlook. With a beta of 1.35, Syncom is classified as a high beta stock, indicating that it tends to exhibit greater volatility compared to the broader market.